Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255238 | SCV000321711 | pathogenic | not provided | 2016-06-21 | criteria provided, single submitter | clinical testing | The c.631_632delAT variant in the GCH1 gene has been reported previously in multiple individuals with dopa-responsive dystonia (Furukawa et al., 1998; Bandmann et al., 1998; Clot et al., 2009; Sun et al., 2014). The c.631_632delAT variant causes a frameshift starting with codon Methionine 211, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 38 of the new reading frame, denoted p.Met211ValfsX38. This variant is predicted to cause loss of normal protein function through protein truncation. The c.631_632delAT variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.631_632delAT as a pathogenic variant. |
Centre for Mendelian Genomics, |
RCV001197727 | SCV001368506 | pathogenic | Dystonia 5 | 2018-10-29 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2. |
Invitae | RCV001221402 | SCV001393445 | pathogenic | Dystonia 5; GTP cyclohydrolase I deficiency | 2019-07-08 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the GCH1 gene (p.Met211Valfs*38). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 40 amino acids of the GCH1 protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals and families affected with dopa-responsive dystonia (PMID: 9778264, 19491146, 23430498). ClinVar contains an entry for this variant (Variation ID: 265173). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV001266568 | SCV001444744 | pathogenic | Inborn genetic diseases | 2020-03-24 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000255238 | SCV001446691 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing |